We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$134B
AUM Growth
-$18.7B
Cap. Flow
-$13.8B
Cap. Flow %
-10.35%
Top 10 Hldgs %
29.65%
Holding
5,915
New
337
Increased
1,382
Reduced
3,110
Closed
265

Sector Composition

Rank Sector Weight
1 Technology 12.02%
2 Healthcare 5.4%
3 Consumer Discretionary 4.87%
4 Financials 4.64%
5 Industrials 3.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHH icon
3951
Howard Hughes
HHH
$3.94B
$48.5K ﹤0.01%
686
-4,027
-85% -$304K
PBE icon
3952
Invesco Biotechnology & Genome ETF
PBE
$286M
$48.5K ﹤0.01%
850
ICVT icon
3953
iShares Convertible Bond ETF
ICVT
$6.97B
$48.3K ﹤0.01%
651
+1
+0.2% +$76
RDFN
3954
DELISTED
Redfin
RDFN
$48.3K ﹤0.01%
6,861
-31,415
-82% -$345K
OPRX icon
3955
OptimizeRx
OPRX
$120M
$48.1K ﹤0.01%
6,189
-5,070
-45% -$55.2K
TBPH icon
3956
Theravance Biopharma
TBPH
$873M
$48.1K ﹤0.01%
5,579
-19,054
-77% -$184K
IXUS icon
3957
iShares Core MSCI Total International Stock ETF
IXUS
$56.8B
$48K ﹤0.01%
800
-3,574
-82% -$223K
TGH
3958
DELISTED
Textainer Group Holdings limited
TGH
$47.6K ﹤0.01%
1,277
-12,704
-91% -$508K
SPOK icon
3959
Spok Holdings
SPOK
$229M
$47.5K ﹤0.01%
3,332
-1,975
-37% -$26.5K
SQQQ icon
3960
ProShares UltraPro Short QQQ
SQQQ
$2.31B
$46.9K ﹤0.01%
92
VLRS
3961
Controladora Vuela Compania de Aviacion
VLRS
$869M
$46.5K ﹤0.01%
6,855
-210
-3% -$2.27K
CANO.WS
3962
CALL
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
$46.5K ﹤0.01%
929,899
NKTR icon
3963
Nektar Therapeutics
NKTR
$2.39B
$46.4K ﹤0.01%
5,199
+4,951
+1,996% +$47.7K
CSTL icon
3964
Castle Biosciences
CSTL
$742M
$46.1K ﹤0.01%
2,730
-8,443
-76% -$148K
OBDC icon
3965
Blue Owl Capital
OBDC
$5.35B
$46.1K ﹤0.01%
3,328
+2,631
+377% +$36.3K
DAC icon
3966
Danaos Corp
DAC
$2.52B
$46.1K ﹤0.01%
696
-43
-6% -$2.89K
BLBD icon
3967
Blue Bird Corp
BLBD
$2.29B
$46.1K ﹤0.01%
2,158
-5,416
-72% -$115K
FREE
3968
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$46K ﹤0.01%
12,776
+12,122
+1,854% +$46.3K
FNDF icon
3969
Schwab Fundamental International Large Company Index ETF
FNDF
$24.4B
$45.9K ﹤0.01%
1,449
-73
-5% -$2.37K
ELVN icon
3970
Enliven Therapeutics
ELVN
$3.78B
$45.7K ﹤0.01%
3,347
-7,476
-69% -$126K
FEP icon
3971
First Trust Europe AlphaDEX Fund
FEP
$515M
$45.7K ﹤0.01%
1,383
IDT icon
3972
IDT Corp
IDT
$1.67B
$45.3K ﹤0.01%
2,056
-7,302
-78% -$172K
ARKW icon
3973
ARK Web x.0 ETF
ARKW
$1.6B
$45.2K ﹤0.01%
835
-1,431
-63% -$84.8K
GDRX icon
3974
GoodRx Holdings
GDRX
$1.09B
$45K ﹤0.01%
7,997
+6,006
+302% +$40K
SHC icon
3975
Sotera Health
SHC
$5B
$44.9K ﹤0.01%
3,000
-4,906
-62% -$82.8K

Similar funds

Citigroup's Q3 2023 Portfolio in Review

As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.

  • Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
  • Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
  • Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
  • Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
  • Citigroup opened 337 new positions and closed 265 in Q3 2023.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.